Diabetes Management Certificate

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

This certificate is intended for pharmacists seeking to expand their knowledge and skills in diabetes management.

Introduction to Diabetes Management and Education
ACPE: 0204-0000-26-764-H01-P
Application-based
2.25 contact hours 

Learning Objectives:

• Apply the recommendations for strengths-based, person-centered language in diabetes.
• Recognize words and phrases that are unhelpful in diabetes.
• Identify professional resources for diabetes language.
• Compare the pathophysiology of at least six types of diabetes.
• Explain the appropriate screening and diagnostic criteria used for different types of diabetes.
• Differentiate treatment options for patients with various types of diabetes other than type 2.
• Describe the importance of diabetes self-management education and support to improve outcomes.
• Utilize principles of motivational interviewing in a patient encounter.  

Goals of Diabetes Management
ACPE: 0204-0000-26-765-H01-P
Application-based
1.25 contact hours 

Learning Objectives:

• Develop individualized glucose goals for different types of patient scenarios.
• Compare and contrast self-monitoring of blood glucose to continuous glucose monitors.
• Design a glucose monitoring plan for a given patient scenario.
• Describe the microvascular and macrovascular complications of diabetes.
• Apply current recommendations for the screening of chronic complications in patients with type 1 and type 2 diabetes.
• Apply current treatment goals and recommendations to prevent and/or slow the progression of chronic complications in patients with type 1 and type 2 diabetes. 

Nutrition, Exercise, and Weight Management
ACPE: 0204-0000-26-766-H01-P
Application-based
3.75 contact hours 

Learning Objectives:

• Discuss the impact of physical activity on glucose management including types of activity, safety concerns, and medication adjustments.
• Recommend physical activity using a strengths-based approach.
• Apply the most recent evidence-based guidance about nutrition for adults with type 1, type 2, and pre-diabetes with considerations for weight management and disordered eating.
• Evaluate evidence-based eating patterns for people living with diabetes and teaching resources for these options.
• Compare approaches to diabetes nutrition such as carbohydrate-restricted, intermittent fasting, and personalized nutrition with gut microbiome.
• Apply appropriate person-centered nutrition approaches to people with diabetes and pre-diabetes.
• Discuss challenges to diabetes self-management including stress, sleep, support, mental health, diabetes distress/burnout, and social determinants of health.
• Discuss pathophysiological concepts related to obesity.
• Summarize current evidence-based recommendations for the treatment of obesity.
• Develop a treatment plan for a person with obesity and diabetes. 

Diabetes Treatment: Oral and Non-Insulin Injectables
ACPE: 0204-0000-26-767-H01-P
Application-based
1.5 contact hours 

Learning Objectives:

• Apply drug mechanisms of action through a pathophysiologic treatment approach.
• Compare and contrast drug therapy efficacy and monitoring parameters to determine appropriate use through evidence-based medicine.
• Discuss patient- and provider-perceived barriers to drug therapy.
• Recommend drug therapy for specific patient case scenarios.
• Design shared decision discussions about drug therapy to reduce clinical inertia. 

Diabetes Treatment with Insulin
ACPE: 0204-0000-26-768-H01-P
Application-based
1.75 contact hours 

Learning Objectives:

• Compare types of insulin and their distinguishing characteristics.
• Calculate insulin doses for a person with a new diagnosis of type 1 diabetes.
• Explain how to safely add insulin to non-insulin agents.
• Design an insulin regimen based on individual patient factors.
• Modify a treatment plan for a person who requires intensification of insulin therapy.
• Adjust treatment plans using pattern management skills based on episodes of hypo- or hyperglycemia, and other treatment considerations. 

Diabetes Treatment for Patients with Cardiovascular and Renal Disease
ACPE: 0204-0000-26-769-H01-P
Application-based
2.75 contact hours 

Learning Objectives:

• Interpret the historical significance behind the requirement for cardiovascular outcomes trials.
• Apply evidence from the cardiovascular outcomes trials for DPP-4 inhibitors, GLP-1 and GIP/GLP-1 receptor agonists, and SGLT2 inhibitors to support therapeutic recommendations for people with type 2 diabetes and atherosclerotic cardiovascular disease.
• Apply evidence from the cardiovascular outcomes trials for DPP-4 inhibitors, GLP-1 and GIP/GLP-1 receptor agonists, and SGLT2 inhibitors to support therapeutic recommendations for people with type 2 diabetes and heart failure.
• Discuss the onset, prognosis, and etiology of chronic heart failure in people with type 2 diabetes.
• Describe clinical practice considerations for the management of people with type 2 diabetes and chronic heart failure.
• Apply evidence from the cardiovascular and kidney outcomes trials for SGLT2 inhibitors and GLP-1 agonists to support therapeutic recommendations for people with type 2 diabetes and chronic kidney disease.
• State the proposed rationale for the kidney protective effects of SGLT2 inhibitors and GLP-1 agonists.
• Modify antihyperglycemic therapy according to current recommendations for kidney dosing adjustments.
• Apply evidence from the cardiovascular and kidney outcomes trials to support therapeutic recommendations for people with type 2 diabetes.
• Design a treatment plan to optimize glycemic management in people with type 2 diabetes, taking coexisting conditions and patient-specific factors into consideration. 

Acute Complications: Hypoglycemia and Hyperglycemia Crises
ACPE: 0204-0000-26-770-H01-P
Application-based
1.25 contact hours 

Learning Objectives:

• Describe strategies and treatments currently available for the management of hypoglycemia.
• Differentiate between glucose-lowering medications based on their risk of contributing to hypoglycemia.
• Design an appropriate treatment and monitoring plan for a person with hypoglycemia unawareness.
• Apply recommendations for hypoglycemia prevention and treatment to a patient case scenario.
• Differentiate the pathophysiology behind diabetic ketoacidosis and hyperosmolar hyperglycemic state.
• Design an appropriate treatment plan for managing hyperglycemic crises. 

Diabetes Technology
ACPE: 0204-0000-26-771-H01-P
Application-based
4.25 contact hours 

Learning Objectives:

• Discuss clinical guidelines and evidence supporting use of continuous glucose monitoring (CGM).
• Compare and contrast continuous glucose monitoring devices.
• Design a treatment regimen based on continuous glucose monitoring data.
• Use the DATAA tool to engage in discussion with a person with diabetes about their glucose data.
• Describe how continuous glucose monitoring data is integrated with connected devices.
• Discuss critical teaching content before starting insulin pump therapy.
• Compare and contrast the currently available insulin pumps.
• Utilize insulin pump data to adjust treatment.
• Evaluate the quality of diabetes-related mobile applications using evidence-informed criteria.
• Differentiate between the various diabetes-related mobile applications available.
• Apply the utility of a mobile application’s characteristics and functionalities to a patient-specific scenario. 

Pharmacotherapy for Diabetes-Related Complications
ACPE: 0204-0000-26-772-H01-P
Application-based
1.25 contact hours 

Learning Objectives:

• Summarize current evidence-based recommendations for the management of macrovascular complications for people with diabetes.
• Recommend a treatment plan for a person with diabetes and macrovascular complications. 

Special Populations
ACPE: 0204-0000-26-773-H01-P
Application-based
3.5 contact hours 

Learning Objectives:

• Use current guidelines to guide therapy decisions in older adults with diabetes.
• Use patient-specific characteristics to individualize A1C and blood glucose goals.
• Compare the potential risks versus benefits of therapies for older adults.
• Evaluate medication regimens in patients with diabetes to identify opportunities for safe and appropriate deprescribing.
• Summarize recent epidemiologic data regarding diabetes within the pediatric population.
• Differentiate common symptoms for children with new onset diabetes and review appropriate diagnostic criteria.
• Prioritize diabetes education and management strategies based on the child/adolescent’s age, development, home environment, and school setting.
• Design an insulin regimen for pediatric patients with type 1 diabetes that takes patient-specific parameters into consideration.
• Identify pediatric-specific considerations for delivering insulin and utilizing insulin technology.
• Develop a monitoring plan for type 1 diabetes complications for pediatric patients.
• Identify children who should be screened for type 2 diabetes.
• Recommend treatment plans for pediatric patients with type 2 diabetes.
• Develop a plan to monitor for complications of diabetes in pediatric patients according to American Diabetes Association Standards of Care.
• Describe the diagnostic criteria for gestational diabetes.
• Discuss glucose targets for pregnancy.
• Design a treatment regimen for a person with gestational diabetes or pregestational diabetes. 

Ambulatory Care Roles in Diabetes
ACPE: 0204-0000-26-774-H01-P
Application-based
3.25 contact hours 

Learning Objectives:

• Apply evidence-informed principles for successful integration within an interprofessional care team.
• Compare the various certifications available for pharmacists whose practice focus is diabetes care.
• Identify healthcare payers and reimbursement methods for healthcare services.
• Explain the required elements of a healthcare billing claim.
• Describe the general rules around reimbursement for pharmacist services from Medicare, Medicaid, and commercial payers.
• Identify sustainable reimbursement opportunities for pharmacists providing diabetes services in various practice settings.
• Apply rules and regulations related to the billing codes available to pharmacists for reimbursement of diabetes care services.
• Differentiate population health and chronic care management approaches for people with diabetes.
• Develop strategies to improve the health of a diabetes population.
• Interpret quality measure reports to establish target measures of population health initiatives.
• Recommend digital health applications based on patient-specific monitoring needs and technology desires for people with diabetes.
• Compare and contrast different cost savings programs for people with diabetes.
• Recommend a cost-saving strategy for a person having difficulty paying for diabetes medications. 

Diabetes Management in the Hospital Setting
ACPE: 0204-0000-26-775-H01-P
Application-based
3.25 contact hours 

Learning Objectives:

• Compare various approaches to achieving good glycemic management in the hospital setting.
• Apply current standards of inpatient care to manage hospitalized patients with hyperglycemia or diabetes.
• Use effective strategies to safely optimize the glycemic management of hospitalized patients with diabetes and hyperglycemia.
• Interpret blood glucose data to improve glycemic management across the hospital.
• Prioritize the need to improve quality of care for hospitalized patients with diabetes through institutional policy and protocol development.
• Design hospital policies and protocols that align with recommendations from national organizations to optimize patient care outcomes.
• Describe the impact of diabetes management teams on the quality of care of hospitalized patients with diabetes.
• Design an institutional diabetes management team using current best practices as a framework.
• Recommend specific strategies to ensure safety and quality in inpatient glycemic management.
• Recommend insulin regimens for hospitalized patients with hyperglycemia based on patient-specific characteristics and current glycemic patterns.

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

The following people in control of this activity’s content have relevant financial relationships:

• Jennifer Clements: Novo Nordisk - speakers' bureau (Ozempic, Rybelsus), Lilly - speakers bureau (Zepbound, tirzepatide), Sanofi – consultant
• Diana Isaacs: Dexcom – speaker, Abbott – speaker, Insulet – speaker, Sanofi – speaker, Sequel – speaker, Novo Nordisk – speaker, Lilly – speaker
• Christie Schumacher: Abbott - speakers bureau
• Elizabeth Van Dril: Bayer - co-investigator for the REACH award 

All other people in control of content do not have any relevant financial relationships with an ineligible company. 

As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.

Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

Important Note – ACPE 60 Day Deadline:

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, check your NABP profile account to validate that your credits were transferred successfully before the ACPE 60-day deadline. After the 60-day deadline, ASHP will no longer be able to award credit for this activity. 

ASHP PROFESSIONAL CERTIFICATES℠ contain learning activities that are ACPE-accredited knowledge and application-based continuing education. This is not an ACPE Certificate Program. Upon successful completion of the activities, the learner will be able to download an ASHP Professional Certificate.